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Background: 
Outcomes in oesophageal atresia (OA) have improved in the last 50 years with survival now of more 
than 90% [1-3] leading to an increasing population of long term survivors. Whilst our understanding 
of short term outcomes in infants with OA is good [4-7], longer term functional outcomes are more 
poorly understood with a limited research base [8-10]. There is increasing interest therefore in 
longer term outcome studies, and results of such studies potentially impact current practice in 
management of OA. This may be especially important for transitional care as patients leave the care 
of the paediatric surgeon for the adult world. The current literature tends to be limited to small 
national [4, 9] and institutional datasets or meta-analysis of such studies [8]. Patient reported 
outcomes (PROMS), as an adjunct to reporting of outcomes by physicians and surgeons are 
becoming increasingly recognised as very important for improving care in a variety of conditions [11, 
12]. 
The Federation of Esophageal Atresia and Tracheo-Esophageal Fistula support groups (EAT) is an 
international federation of patient support groups (Table 1), led by patients and parents aiming to 
share the international knowledge and experience of OA, promote awareness of the condition 
across the world and support worldwide research and collation of information concerning the 
treatment and care of people born with esophageal atresia. EAT therefore has a keen interest in the 
short and long term outcomes of OA and have first-hand experience of the difficulties faced by many 
patients and carers at all times in their journey from diagnosis though transition and on into adult 
care. In order to gain an idea of the patient-reported outcomes in OA, EAT has conducted a patient 
and carer designed and led study.  This paper aims to report the data from this unique study in order 
to provide insight into patient-reported short and long term outcomes of OA in a large international 
cohort of patients with OA. 
  
Methods: 
This study was conceptualised as a questionnaire which was then designed by the board of EAT (see 
author list) with support from a Professor of Quality of Care (MvD). It was designed to be a patient / 
carer focussed study looking at outcomes of specific interest to those groups. The questionnaire was 
therefore designed to assess the following keys areas of interest: 
1. Current symptomatology  
2. Patient / carer satisfaction  
3. Quality of life (QoL) 
Demographics and operative details were also obtained as part of the questionnaire in order to 
describe the OA population surveyed. A questionnaire then piloted within the EAT board, prepared 
in multiple languages (English, Dutch, German, French and Italian) and put in an electronic format 
using SurveyMonkey®. Invitations to participate were sent electronically to all members of 11 
different European patient support groups (Table 1). This included patients and carers in 24 different 
countries, as members of the support groups sometimes resided outside of Europe.  
 
Where possible, patients completed the questionnaire; otherwise this was performed by carers. 
Completed questionnaire were collected centrally, collated and analysed anonymously. Initial data 
was presented by the Chairman of EAT at British Association of Paediatric Surgeons Congress 
(Cardiff, 2015). Following this the organisation approached UCL Institute of Child Health for 
assistance in data analysis and interpretation. Formal ethics approval was not initially sought as this 
was a patient group led study. Approval was obtained for anonymised data analysis from ICH / GOSH 
Research & Development office at (project number 16DS21). Initial data were cleaned and duplicate 
responses excluded, together with responses where date of birth was not completed.  Responses 
with missing or duplicate data for individual questions were included for those questions answered 
and percentages calculated from only completed answers. 
Patient height and weight were analysed using standard deviation scores (SDS) using LMS Growth 
Excel Plug In version 2.69 and UK-WHO Growth Charts in respondents under 18 years old. Body mass 
index was calculated for those 18 years and over and compared to the WHO International 
Classification. Data were compared by Fisher’s exact test or Mann-Whitney, regarding p=0.05 as the 





1100 responses were received from an estimated 2500 members of EAT organisations invited to 
participate. Following exclusions, 928 responses (56% male and 44% female) were analysed with a 
patient age range of 1 month to 60 years of age. For analysis, patients were divided into the 
following age groups, <5 years (42% of responses), 5-10 years (26%), 11-17 years (16%) and 18 years 
and over (16%).  
Responses were received from 25 different countries (Figure 1). Smaller numbers of responses were 
also received from Canada, USA, Ireland, South Africa, New Zealand, Spain, Guadeloupe, Tunisia, 
Sweden, Malta, Lithuania, Israel, Hungary, Hong Kong, Greece and Denmark in decreasing order of 
number of responses. 121 (18%) of responses were completed by patients and 761 (82%) by a 
parent or carer.  
OA with trachea-oesophageal fistula (OA-TOF) was the most common defect, reported in 80% of 
cases, 19% were pure OA and 1% an H type fistula. Participants reported their defect as ‘long gap’ 
either as supplementary to reporting the anatomy of their defect or as an isolated diagnosis in 18% 
of cases. Similar distribution of type of defect was seen in all age groups although there was a 
significantly higher proportion of pure OA and long gap participants in the adult age group with 13% 
of cases being pure OA in participants under 18 versus 23% in the adult cohort (p=0.004). 
Surgical Care 
Overall, the median length of hospital stay following initial surgery was 6 weeks (range 1 to 174 
weeks). However, considering only the respondents over 18, the median length of was 8 weeks (IQR 
= 16). When compared by diagnosis, those with OA-TOF had a median LoS of 6 weeks (IQR) versus 8 
weeks for those with pure OA (IQR). Long gap cases reported median LoS was 18 weeks (IQR) versus 
5 weeks (IQR) for standard gap OA. Fifty-three percent (0-5 years), 46% (5-10 years) and 52% (11-17 
years) of participants in the younger age groups respectively only required 1 operation to repair 
their defect, whereas in the 18 year and above group only 36% were repaired with a single operation 
and 45% needed 2-5 procedures.  
The proportion of patients receiving dilatation following repair is summarised in Figure 2. Forty-nine 
percent of all respondents had oesophageal dilatation and the number of dilatations received was 
broadly similar across each age group. If dilatation was performed the median number was 4 
dilatations and was the same for all age groups. The median number of reported dilatations in 
participants with long gap OA was 2 (IQR 0-10) and was significantly higher (p<0.001) than in those 
with standard gap who reported a median of 0 dilatations (IQR 0 – 5). Those respondents reporting 
reflux symptoms had a significantly higher median number of dilatations at 1 (IQR 0-5) than those 
without symptoms where the median number of dilatations was 0 (IQR 0-3; p=0.01). 
Symptomatology 
Across all participants, 65% reported that they could ‘eat anything’ with no restrictions on type of 
food. In those under 5 years, this figure was only 50% which was significantly less than those over 5 
years old in which 75% reported they could ‘eat anything’ (p<0.0005). In those with long gap defects, 
only 35% of those under 10 reported that they could eat without restriction. 
Figure 3 shows how frequently participants in different age groups reported food getting stuck in the 
oesophagus. The patterns across age groups are broadly similar with 16% of participants often 
getting food stuck and only 22% reporting never having food stick. Over 50% of adult patients (18 
years and above) report sometimes or often getting food stuck in the oesophagus. 
58% percent of respondents reported gastro oesophageal reflux symptoms and a similar incidence 
was seen in all age groups; 65% in <5 years, 53% in 5-10 years, 54% in 11-17 years and 60% in adults. 
When analysed by gap length, 78% of those with long gap defects reported suffering from reflux 
symptoms versus 55% of respondents with standard gap length (p<0.005). The use of anti-reflux 
medication showed a decreasing trend with age.  Reflux medication was reported being taken by 
60% of under 5s but only 30% of adult participants, despite a similar proportion in each age group 
reporting symptoms.  
Respiratory problems were commonly reported by participants and show a decreasing trend with 
age. (Fig 4). Patients with long gap OA more often reported respiratory symptoms with 42% of under 
5s and 24% of 5-10 year old with long-gap reporting ‘often’ having symptoms compared to 16% and 
8% respectively in standard gap patients. There is a similar decreasing trend with age in the 
incidence of chest infections with 30% of children under 5 years reporting having more than 3 chest 
infection per year but only 14% of adults reporting the same frequency of infections (Figure 5). Long 
gap patients did not report more frequently occurring chest infections than standard gap patients 
except in the under 5’s. 
Regular antibiotic usage has shown similar decreasing trend in the use of with 17% of 0–10 year olds 




On average, children <18 years with OA were slightly less than average weight and height, with 
median SDS scores of -0.41 (IQR -1.4 to +0.67) for height and -0.63 (IQR -1.6 to 0.17) for weight, 
where population averages are zero (Fig 6A). BMI in respondents 18 years and over is shown in 
Figure 6B. Two percent of adult respondents reported weight and height that put them in the obese 
BMI category, 15% were overweight, 62% were normal weight and 21% were underweight. The 
mean BMI was 21.5.  
Care Provision 
Current care provision is shown in Figure 7. Twenty-two percent of children under 5 are reported not 
to be under the care of a paediatric surgeon and there is a trend of fewer participants being looked 
after by paediatric surgeons with increasing age. There is also an increasing trend with age in those 
with no current care provider with 50% of adults not reported being looked after by a general 
practitioner or equivalent primary care physician.    
Quality of life 
The graphs in figure 8 A-D show responses to the questions related to quality of life in the study. 
They demonstrate that whilst 20-25 % of respondents report that OA has had no effect on their own 
or their families QoL a similar proportion of patients suggested their QoL was significantly affected. 




The EAT 1 survey offers unique, international patient directed short, medium and long term follow 
up data on one the largest cohorts of OA patients in the literature to date. It highlights the clinical 
long term morbidity that OA patients suffer from and how these may change with age. It also 
importantly examines the often ignored quality of life issues faced by this patient group. The large 
size of this study group makes it more representative of the wider international population of OA 
patients than most of the existing literature which is limited to smaller national [4, 10] and 
institutional data series [3, 7, 13] or meta-analyses [8]. The study participants are broadly 
representative of the wider population based on anatomy of original defect in comparison to 
EUROCAT figures [14]. The significantly higher incidence of pure and long gap OA in the adult group 
probably represents the demographics of adult patients accessing support groups i.e. those with 
more complex conditions and a similar pattern of recruitment is seen in the German support group 
(KEKS) quality of life (QoL) study [15]. While ongoing care is expected for most complex patients 
during their adult life, this is also one of the limitations of studies like ours in which responders are 
recruited via a patient specific association and should be taken into account during counselling. The 
age range of participants studied again makes this study unique including infants up to the oldest 
subject who was 60 years of age at completion of the survey. The fewer patients in the older age 
range may be the result of several factors including the previous limited survival of babies in the 
early years of OA surgery, the relatively new development of patient support groups – through 
which recruitment took place and also the perceived need of such support groups in older patients. 
The geographic spread of participants represents the principal patient support groups involved in 
the study and membership in each of those countries.  
The anthropometric data collected in this study is consistent with existing literature [16-18] 
suggesting that as children, patients with OA tend toward being underweight and to a less extent 
shorter than the normal population. Interestingly, we showed a significantly lower mean score for 
height in under 5s than older children. It may represent a sampling weakness as these were self-
recorded and reported outcomes in an age group in which it may be difficult to get accurate 
length/height measurements. Chetcuti et al reported that there is ‘catch up’ growth as children 
become adolescents and then adults[17]. The median BMI of the adult group is within the normal 
range at 21.5 suggesting catch-up growth, although there are still 21% of adults classed as 
underweight by BMI and a much lower level of obesity (2%) in this patient population than in the 
normal European population (15-30%). 
The post-operative management of OA has improved over the last 2 decades and this may explain 
the shorter length of stay seen in the younger participants. However, the groups are not evenly 
matched for type of defect and gap length and the higher incidence of long gap and pure OA in the 
adult group may account for the increased median length of stay and number of operation required.  
With increasing clinical and research interest in the long term follow up of OA patients, reported 
outcomes relating to symptomatology and quality of life in such a large patient cohort are important 
additions to the literature. Dysphagia and reflux are well reported in the short and long term after 
OA repair and we see a high reported incidence of food ‘getting stuck’, a surrogate patient reported 
outcome for dysphagia, in agreement with published literature [8] [16]. Previous studies have 
reported reflux symptoms in nearly 50% of under 5’s  with a decreasing frequency with age.  We 
however found a higher reported incidence of reflux in the under 5’s (65%) and this did not decrease 
significantly with age with 60% of adults reporting symptoms. Meta-analysis reports a lower (40%, 
range 18-64%) of reflux symptoms but recognises the variation in definition of GOR across studies 
analysed. We are also limited in our analysis by the lack of definition of our patient report outcomes 
but our findings add to the increasing body of literature highlighting long term morbidity in adult OA 
patients. The limited use of reflux medication in our adult cohort (30%), despite the high reported 
incidence of symptoms (60%was striking and is similar to that reported [19]. Schneider et al. went on 
to endoscope a cohort of adult OA patients and concerningly found that 67% of patients had 
histological evidence of oesophagitis and 43% Barrett’s oesophagus [19]. Several other studies 
report an increased risk of Barrett’s [9, 20] in OA and whilst a definitive increased risk of 
oesophageal cancer in OA patients has yet to be proven [8, 21] the frequency of reflux symptoms in 
this patient group and histological metaplastic changes mean more attention needs to be paid to the 
consideration of surveillance endoscopy and use of anti-reflux medication in the adult aged OA 
population.  
Respiratory symptoms are another important morbidity following OA repair, with 38% of all patients 
and 39% of adult patients reporting sometimes or often suffering from respiratory symptoms a 
figure. Respiratory infections however do appear to be less frequent in the older patients with nearly 
30% of under 5 year olds having >3 chest infections per year, falling to 8% and 13% in the older age 
groups. Connors et al suggested an overall prevalence of 24% for respiratory tract infections but with 
a range of 9.5 – 51% [8]. It is difficult to accurately compare the data from our study and to calculate 
the prevalence but the there is a similar message that whilst respiratory tract infections may 
decrease in frequency with age a third of patients with OA report ongoing respiratory symptoms 
though school years and adulthood. 
The ongoing gastroenterological and respiratory morbidity in OA patients leads to the question of 
who provides care for this patient group. Whilst there is international variation in the way care is 
provided to these patients what is clear is that whilst only 5–10% of children under 10 years have no 
documented care provider (which remains   concerning), this increases to 49% in the adults. 
Although it is possible that some adult patients have no medical input because they are 
asymptomatic and feel that they do not ‘need’ regular medical input, the high incidence of reflux 
and respiratory symptoms seen in this and other studies may suggest more patients should have a 
regular care provider with experience in OA / TOF, and that the higher number of adults not under 
regular care may reflect the relatively recent emphasis that is being put on transitional care and long 
term outcomes. This is an area of great concern to many patients.  
As expected in our study there is a decrease with age in the number of patients looked after by 
paediatric surgeons. This may be a result of differences in practice across the countries in the study, 
where the longer term care of OA is led by gastroenterologists as opposed to surgeons or that if 
children are well they may be referred back to primary care. Adult patients appear to be discharged 
or transitioned to the gastroenterologist who provide the care to 28% of those over 18 years in our 
study. How transition is managed in the future is an important issue for OA care and other chronic 
paediatric conditions, as the population of long term survivors continues to increase. International 
studies such as this alongside work from Australia [22], Finland [9, 10] Holland [23, 24] and more 
recently the USA [25] are key in highlighting the need for careful planning of patient centred 
transitional and adult care. This may include the need for some stratification of transition and follow 
up. Our results demonstrate a wide spectrum of morbidity experienced by OA patients, many may 
therefore need minimal long term follow up whilst others with more significant morbidity will 
require regular tertiary level or hospital follow up. Early characterisation of patients ‘at risk’ of long 
term problems from more detailed future studies may help streamline the transition process.   
Forward thinking centres are already looking at ways to improve the transitional care process with a 
German centres offering education sessions for OA patients coming up to transition [26] and there is 
an increasing research effort examining what improves transition across all conditions [27].  
Quality of life in OA patients is an outcome that had limited attention from surgeons in the past but 
is of increasing interest. These data show that 17% of patients / parents report a ‘significantly’ 
affected QoL and demonstrate more attention needs to be paid in this area – especially as 21% and 
27% also report ‘significant’ effects on education or work and other family members respectively. 
QoL in OA has been reported as being ‘comparable’ with the normal population by the German 
support group (KEKS)[15]. They did however also find that health related quality of life (HRQoL) in 
adults is negatively affected by disease specific symptoms such as reflux and respiratory symptoms, 
a result also seen in other QoL studies [28, 29]. It is difficult to make direct comparisons between 
this and other QoL studies, as this study used patient-led questionnaires whereas other studies have 
used validated QoL tools. Nevertheless, the parent/patient led description of impaired QoL, and the 
finding that nearly 90% of parents of under 5 year olds reporting an effect on their child’s education 
demands attention. 
Comparison of our results to that of the KEKS study is useful as both studies examine outcomes of 
patients identified through patient support groups. However the use of support groups for 
recruitment may bias results and make comparison to the wider OA population difficult as their 
membership may be made up of those who require more ‘support’ and have a higher severity of 
disease. The variability in recruitment in different counties probably represents the activity and 
membership of the different national support organisations of EAT as opposed to proportional size 
of OA populations in each country. Therefore comparison of outcomes between countries is not 
possible and generalization of results across countries must be done with caution.   
The questionnaire used in this study was specifically patient designed and easy to understand and 
complete and whilst this maximised recruitment it did lead to data being limited in detail for 
example of comorbidities and specific surgical detail. As a pilot study however its strengths lie in the 
numbers of participants recruited across over 20 countries and firmly establishing the scale and 
types of morbidity seen across all ages of the OA population.  
Another important message from this work is that of collaboration, which has been the key to this 
project as the patient support groups of Europe worked together towards a common goal. In the 
literature to date collaboration is limited in OA research as centres have tended to publish their own 
limited series. More recently larger national and international collaborations have led to more 
representative studies and with projects such as the European Reference Network of Rare Inherited 
and Congenital  Anomalies (ERNICA) being developed it is hoped clinicians and research groups can 
learn from the example set by this patient led project and achieve better quality studies and 
outcomes through wider collaborative work. The EAT study is testimony to the commitment and 
drive of the OA patient community and support groups to work together and produce clinically 
relevant and effective research in attempts to improve clinical care. Now that the EAT 1 study has 
given a broad baseline of the scale of gastroenterological, respiratory and QoL morbidity seen in OA 
patients, a more detailed and focussed study of a smaller cohort of these patients is being designed. 
  
Legends:  
Table 1: Member organisations of EAT 
Figure 1. Respondents by Country  
Figure 2. Numbers of dilatations by age 
Figure 3. Frequency of food bolus sticking by age 
Figure 4. Frequency of respiratory problems 
Figure 5. Frequency of chest infections by age 
Figure 6. Height and weight by age. A) SDS score in under 18 yrs, B) BMI in adult patients  
Figure 7. Current care provision by age group 
Figure 8. Quality of life. Frequency of impact of OA on A) quality of life, B) on other family members, 




This collaborative work has involved many different people from the design of the study through to 
data collection and subsequent analysis.  
The advisory work and support of Prof Rene Wijnen, Head of Paediatric Surgery and Professor 
Monique van Dijk and their colleagues at Sofia Children’s Hospital, Erasmus MC is greatly 
appreciated. Prof van Dijk advised on questionnaire design.  
All member groups and the patients of EAT are acknowledged for their assistance in making this 
study possible.   
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Table 1 
Organisation  Country  
AFAO Association Francaise de l’Atresie de l’Oesophage France 
ABeFAO Association Belge Francophone de l’Atrésie de 
l’Oesophage 
Belgium 
FATE Famiglie con Atresia dell’Esofago Italy  
KEKS Kinder und Erwachsene mit kranker Speiseröhre Germany 
KEKS Kinder und Erwachsene mit kranker Speiseröhre Austria 
OARA Oesophageal Atresia Research Association Australia 
OA-Switzerland  OA-Switzerland  Switzerland 
TOFS Tracheo-Oesophageal Fistula Support  United 
Kingdom 
TROAD Türkiye Özofagus Atrezisi Çocuk ve Aile Destek 
Derneği 
Turkey 
VOKS Vereniging voor Ouderen en Kinderen met een 
Slokdarmafsluiting 
Netherlands  
AQAO Association Quebecoise de l’Atresie de l’Oesophage Canada 
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